期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 57, 期 11, 页码 5767-5770出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01032-13
关键词
-
资金
- Fondo de Investigacion Sanitaria (FIS) [PI11/00167]
- Astellas Pharma
- FIS [CD09/00230, MS09/00055, FI12/00265, CD11/00110]
We compared the ability of the EUCAST EDef 7.2 and the Etest to detect the susceptibility to micafungin of 160 Candida and non-Candida clinical isolates. Agreement was higher when Etest MICs were obtained after 24 h of incubation; essential agreement was 90%, and categorical agreement was >90%. False susceptibility was seen only for Candida krusei (10%), and false resistance was observed in 6% of the isolates, ranging from 2.6% (C. glabrata) to 13% (C. albicans).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据